LifeMD, Inc. (LFMDP)
USD 24.7
(4.11%)
USD 24.7
(4.11%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 58.48 Million USD | 127.85% |
| 2022 | 25.66 Million USD | -48.59% |
| 2021 | 49.92 Million USD | 282.45% |
| 2020 | 13.05 Million USD | 278.79% |
| 2019 | 3.44 Million USD | 31.73% |
| 2018 | 2.61 Million USD | 107.0% |
| 2017 | 1.26 Million USD | 60.01% |
| 2016 | 789.82 Thousand USD | 76.11% |
| 2015 | 448.47 Thousand USD | 155.95% |
| 2014 | 175.22 Thousand USD | -68.23% |
| 2013 | 551.44 Thousand USD | 49.16% |
| 2012 | 369.69 Thousand USD | 7.68% |
| 2011 | 343.33 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 63.82 Million USD | 3.85% |
| 2024 Q1 | 61.45 Million USD | 5.09% |
| 2023 Q1 | 33.86 Million USD | 31.96% |
| 2023 Q4 | 58.48 Million USD | 43.72% |
| 2023 Q2 | 35.44 Million USD | 4.65% |
| 2023 Q3 | 40.69 Million USD | 14.8% |
| 2023 FY | 58.48 Million USD | 127.85% |
| 2022 Q3 | 33.36 Million USD | -12.14% |
| 2022 Q2 | 37.96 Million USD | -24.5% |
| 2022 Q1 | 50.29 Million USD | 0.74% |
| 2022 FY | 25.66 Million USD | -48.59% |
| 2022 Q4 | 25.66 Million USD | -23.07% |
| 2021 FY | 49.92 Million USD | 282.45% |
| 2021 Q3 | 16.35 Million USD | -31.83% |
| 2021 Q4 | 49.92 Million USD | 205.31% |
| 2021 Q2 | 23.98 Million USD | 27.98% |
| 2021 Q1 | 18.74 Million USD | 43.59% |
| 2020 Q3 | 5.42 Million USD | 79.53% |
| 2020 FY | 13.05 Million USD | 278.79% |
| 2020 Q1 | 2.29 Million USD | -33.52% |
| 2020 Q2 | 3.02 Million USD | 32.01% |
| 2020 Q4 | 13.05 Million USD | 140.42% |
| 2019 Q2 | 2.19 Million USD | -16.29% |
| 2019 Q1 | 2.62 Million USD | 0.41% |
| 2019 Q4 | 3.44 Million USD | 35.34% |
| 2019 FY | 3.44 Million USD | 31.73% |
| 2019 Q3 | 2.54 Million USD | 15.79% |
| 2018 Q3 | 1.89 Million USD | 3.34% |
| 2018 FY | 2.61 Million USD | 107.0% |
| 2018 Q4 | 2.61 Million USD | 37.74% |
| 2018 Q2 | 1.83 Million USD | 52.46% |
| 2018 Q1 | 1.2 Million USD | -4.61% |
| 2017 Q1 | 1.07 Million USD | 35.94% |
| 2017 Q2 | 1.15 Million USD | 7.78% |
| 2017 Q3 | 1.33 Million USD | 15.58% |
| 2017 Q4 | 1.26 Million USD | -5.51% |
| 2017 FY | 1.26 Million USD | 60.01% |
| 2016 Q3 | 1.07 Million USD | 24.67% |
| 2016 FY | 789.82 Thousand USD | 76.11% |
| 2016 Q1 | 641.45 Thousand USD | 43.03% |
| 2016 Q2 | 865.78 Thousand USD | 34.97% |
| 2016 Q4 | 789.82 Thousand USD | -26.83% |
| 2015 Q2 | 251.61 Thousand USD | 16.24% |
| 2015 Q4 | 448.47 Thousand USD | 83.04% |
| 2015 Q3 | 245.01 Thousand USD | -2.62% |
| 2015 Q1 | 216.46 Thousand USD | 23.54% |
| 2015 FY | 448.47 Thousand USD | 155.95% |
| 2014 Q2 | 302.16 Thousand USD | -7.74% |
| 2014 Q1 | 327.53 Thousand USD | -40.6% |
| 2014 Q4 | 175.22 Thousand USD | -44.11% |
| 2014 Q3 | 313.48 Thousand USD | 3.74% |
| 2014 FY | 175.22 Thousand USD | -68.23% |
| 2013 Q2 | 461.82 Thousand USD | 26.53% |
| 2013 Q1 | 364.98 Thousand USD | -1.27% |
| 2013 FY | 551.44 Thousand USD | 49.16% |
| 2013 Q4 | 551.44 Thousand USD | 88.22% |
| 2013 Q3 | 292.97 Thousand USD | -36.56% |
| 2012 Q3 | 451.65 Thousand USD | 0.0% |
| 2012 FY | 369.69 Thousand USD | 7.68% |
| 2012 Q4 | 369.69 Thousand USD | -18.15% |
| 2011 FY | 343.33 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 5.25 Million USD | -1011.911% |
| BIMI International Medical Inc. | 35.71 Million USD | -63.745% |
| China Jo-Jo Drugstores, Inc. | 95.05 Million USD | 38.478% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 311.75 Million USD | 81.241% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 312.16 Million USD | 81.266% |
| Leafly Holdings, Inc. | 21.83 Million USD | -167.83% |
| Leafly Holdings, Inc. | 21.83 Million USD | -167.83% |
| LifeMD, Inc. | 58.48 Million USD | 0.0% |
| TRxADE HEALTH, Inc. | 12.53 Million USD | -366.617% |
| PetMed Express, Inc. | 175.09 Million USD | 66.6% |
| Walgreens Boots Alliance, Inc. | 81.03 Billion USD | 99.928% |